{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:00:56Z","timestamp":1777510856117,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1136\/ard.2004.030783","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T18:28:43Z","timestamp":1108146523000},"page":"ii74-ii77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"S2","title":["Psoriatic arthritis therapy: NSAIDs and traditional DMARDs"],"prefix":"10.1016","volume":"64","author":[{"given":"P","family":"Nash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D O","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.030783_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","article-title":"Health related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis","volume":"45","author":"Husted","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib2","first-page":"1041","article-title":"Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis","volume":"28","author":"Rahman","year":"2001","journal-title":"J Rheumatol"},{"issue":"suppl II","key":"10.1136\/ard.2004.030783_bib3","doi-asserted-by":"crossref","first-page":"ii78","DOI":"10.1136\/ard.2004.034157","article-title":"Psoriatic arthritis treatment: biological response modifiers","volume":"64","author":"Mease","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"suppl II","key":"10.1136\/ard.2004.030783_bib4","doi-asserted-by":"crossref","first-page":"ii42","DOI":"10.1136\/ard.2004.031567","article-title":"Science of assessments","volume":"64","author":"Bellamy","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"suppl II","key":"10.1136\/ard.2004.030783_bib5","doi-asserted-by":"crossref","first-page":"ii49","DOI":"10.1136\/ard.2004.034165","article-title":"Psoriatic arthritis assessment tools in clinical trials","volume":"64","author":"Mease","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"suppl II","key":"10.1136\/ard.2004.030783_bib6","doi-asserted-by":"crossref","first-page":"ii61","DOI":"10.1136\/ard.2004.030809","article-title":"Psoriatic arthritis imaging: a review of scoring methods","volume":"64","author":"van de Heijde","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030783_bib7","first-page":"S17","article-title":"The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulide","volume":"19","author":"Sarzi-Puttini","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib8","first-page":"309","article-title":"Exacerbation of psoriasis with meclofenamate","volume":"5","author":"Meyerhoff","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.030783_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.139.9.1223","article-title":"Psoriasis associated with rofecoxib","volume":"139","author":"Clark","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1136\/ard.2004.030783_bib10","first-page":"45","article-title":"Exacerbation of psoriasis by ibuprofen","volume":"38","author":"Ben-Chetrit","year":"1986","journal-title":"Cutis"},{"key":"10.1136\/ard.2004.030783_bib11","first-page":"1356","article-title":"Spondyloarthritis Research Consortium of Canada (SPARCC). Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis","volume":"30","author":"Maksymowych","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib12","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2133.1968.tb11947.x","article-title":"Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases","volume":"80","author":"Baker","year":"1968","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard.2004.030783_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/rheumatology\/29.1.46","article-title":"Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study","volume":"29","author":"Farr","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib14","first-page":"894","article-title":"Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial","volume":"22","author":"Gupta","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/rheumatology\/32.10.923","article-title":"Sulphasalazine in the management of psoriatic arthritis","volume":"32","author":"Fraser","year":"1993","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780380507","article-title":"Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study","volume":"38","author":"Dougados","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib17","first-page":"1957","article-title":"The use of sulfasalazine in psoriatic arthritis: a clinic experience","volume":"25","author":"Rahman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/rheumatology\/35.7.664","article-title":"Sulphasalizine in psoriatic arthritis; a randomized multicentre placebo controlled trial","volume":"35","author":"Combe","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib19","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/art.1780391210","article-title":"Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study","volume":"39","author":"Clegg","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib20","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","article-title":"Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study","volume":"42","author":"Clegg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib21","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.1964.03070100037007","article-title":"Methotrexate therapy in psoriatic arthritis; double-blind study on 21 patients","volume":"189","author":"Black","year":"1964","journal-title":"JAMA"},{"key":"10.1136\/ard.2004.030783_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.1780270403","article-title":"Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis","volume":"27","author":"Willkens","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib23","first-page":"872","article-title":"Psoriatic arthritis: clinical response and side effects to methotrexate therapy","volume":"19","author":"Espinoza","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib24","first-page":"241","article-title":"Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib25","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s100670170004","article-title":"Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis\u2014short- and long-term toxicity in 104 patients","volume":"20","author":"Wollina","year":"2001","journal-title":"Clin Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib26","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/anr.1780320208","article-title":"A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis","volume":"32","author":"Carette","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.1780210504","article-title":"Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis","volume":"21","author":"Dorwart","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/rheumatology\/29.4.280","article-title":"A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis","volume":"29","author":"Palit","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib29","first-page":"139","article-title":"Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?","volume":"18","author":"Mader","year":"1995","journal-title":"Clin Invest Med"},{"key":"10.1136\/ard.2004.030783_bib30","first-page":"1922","article-title":"Longterm therapy of psoriatic arthritis: intramuscular gold or methotrexate?","volume":"27","author":"Lacaille","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/rheumatology\/35.6.564","article-title":"Termination of disease-modifying drugs in psoriatic arthritis: study of 109 courses of treatment","volume":"35","author":"Gomez-Vaquero","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib32","first-page":"20","article-title":"Mechanism of action of leflunomide in rheumatoid arthritis","volume":"53","author":"Fox","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib33","first-page":"S92","article-title":"Leflunomide in psoriatic polyarthritis: an Italian pilot study","volume":"44","author":"Scarpa","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib34","first-page":"S121","article-title":"Long term followup of the use of leflunomide in recalcitrant psoriatic arthritis and psoriasis","volume":"44","author":"Liang","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib35","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","article-title":"Treatment of Psoriatic Arthritis Study Group. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial","volume":"50","author":"Kaltwasser","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/art.1780160202","article-title":"Treatment of psoriatic arthritis with 6-mercaptopurine","volume":"16","author":"Baum","year":"1973","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib37","first-page":"116","article-title":"A double-blind controlled evaluation of azathioprine treatment in rheumatoid arthritis and psoriatic arthritis","volume":"15","author":"Levy","year":"1972","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/ard.49.8.603","article-title":"Cyclosporin A in psoriatic arthritis: an open study","volume":"49","author":"Steinsson","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030783_bib39","first-page":"589","article-title":"Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study","volume":"13","author":"Spadaro","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib40","first-page":"116","article-title":"Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study","volume":"186","author":"Mazzanti","year":"1994","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1136\/ard.2004.030783_bib41","first-page":"1724","article-title":"Chloroquine therapy in psoriatic arthritis","volume":"19","author":"Gladman","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/rheumatology\/25.2.228","article-title":"D-penicillamine and psoriatic arthropathy","volume":"25","author":"Price","year":"1986","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2340\/0001555560515520","article-title":"Therapeutic trials with oral colchicine in psoriasis","volume":"60","author":"Wahba","year":"1980","journal-title":"Acta Dermatol Venereol"},{"key":"10.1136\/ard.2004.030783_bib44","first-page":"777","article-title":"Psoriatic arthritis treated with oral colchicine","volume":"14","author":"Seideman","year":"1987","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib45","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.52.11.826","article-title":"Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis","volume":"52","author":"McKendry","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.030783_bib46","first-page":"789","article-title":"Pilot study of etretinate in psoriatic arthritis","volume":"16","author":"Klinkhoff","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.030783_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0049-0172(92)90036-D","article-title":"Treatment of psoriatic arthropathy","volume":"21","author":"Goupille","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2133.1990.tb08269.x","article-title":"Treatment of psoriatic arthritis by extracorporeal photochemotherapy","volume":"122","author":"Wilfert","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard.2004.030783_bib49","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/art.1780390911","article-title":"Treatment of psoriatic arthritis with extracorporeal photochemotherapy and conventional psoralen-ultraviolet A irradiation","volume":"39","author":"Vahlquist","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.030783_bib50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-4362.1988.tb02341.x","article-title":"Somatostatin treatment of psoriatic arthritis","volume":"27","author":"Matucci-Cerinic","year":"1988","journal-title":"Int J Dermatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724424199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724424199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.030783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T12:38:33Z","timestamp":1737549513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724424199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":50,"alternative-id":["S0003496724424199"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.030783","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriatic arthritis therapy: NSAIDs and traditional DMARDs","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.030783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}